Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 32 Hodgkin Disease 29 Lymphoma 10 Sarcoma 7 Uveal Melanoma 5 Neoplasm Metastasis 4 Neoplasms 3 Leiomyosarcoma 2 HIV Infections 2 Solitary Fibrous Tumors 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma, Synovial 1 Recurrence 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Immunotherapy 1 Hyperthermia 1 Hematologic Diseases 1 Carcinoma 1 Advanced Melanoma 1 Acquired Immunodeficiency Syndrome 1 AIDS-Related Complex 1

Interventions

Cisplatin 24 Carboplatin 19 Paclitaxel 18 pembrolizumab 12 Gemcitabine 12 Radiotherapy 9 Fluorouracil 9 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 cemiplimab 6 Platinum 6 Nivolumab 6 Docetaxel 6 Cetuximab 6 1,2-diaminocyclohexaneplatinum II citrate 6 epothilone B 5 anlotinib 5 Sunitinib 5 Pemetrexed 5 Oxaliplatin 5 Everolimus 5 Drug Therapy 5 Cyclophosphamide 5 Capecitabine 5 Bevacizumab 5 durvalumab 4 Radiotherapy, Intensity-Modulated 4 Radiation 4 Erlotinib Hydrochloride 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma × Dacarbazine × Clear all

NCT00070642 2009-02-10

CPG 7909 Injection in Melanoma

Pfizer

Phase 2 Completed

Carcinoma, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡